Home › NDC Lookup › RxCUI directory › RxCUI 831261

Cromolyn sodium 20 MG/ML Oral Solution — RxCUI 831261

RxNorm drug concept · Semantic clinical drug
RxCUI 831261 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI831261
Official nameCromolyn sodium 20 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascromolyn sodium 100 MG per 5 ML Concentrate for Oral Solution; cromolyn sodium 100 MG in 5 mL Concentrate for Oral Solution
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)15,564 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cromolyn Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — and this is really important to understand. Cromolyn sodium is a preventive medicine only. It does not open your airways once they've tightened up. You should always have a se...
  • Will this inhaler stop an asthma attack if I'm already having one?
  • It can take several weeks of regular use before you feel the full benefit — though some people notice improvement sooner. The key is consistency. Taking it at the same times every...
  • How long does it take before I notice it working?
📖 Read our full Cromolyn Oral Inhalation guide →

🕸️ Concept Web — How Cromolyn sodium 20 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cromolyn sodium 20 MG/ML Oral Solution RxCUI 831261

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cromolyn 42612
    • Cromolyn sodium 3538
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gastrocrom 217266
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cromolyn Oral Solution 378378
    • Cromolyn sodium Oral Solution 2645635
    • Cromolyn Oral Liquid Product 1155847
    • Cromolyn Oral Product 1155848
    • Cromolyn sodium Oral Liquid Product 2660474
    • Cromolyn sodium Oral Product 2661434
    • Cromolyn Oral Solution [Gastrocrom] 364684
    • Cromolyn sodium Oral Solution [Gastrocrom] 2657432
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cromolyn sodium 20 MG/ML SCDC · 360927
  • Cromolyn Oral Solution SCDF · 378378
  • Cromolyn sodium Oral Solution SCDFP · 2645635
  • Cromolyn Oral Liquid Product SCDG · 1155847
  • Cromolyn Oral Product SCDG · 1155848
  • Cromolyn sodium Oral Liquid Product SCDGP · 2660474
  • Cromolyn sodium Oral Product SCDGP · 2661434

Brand-Name Concepts

  • Cromolyn sodium 20 MG/ML Oral Solution [Gastrocrom] SBD · 831269
  • Cromolyn sodium 20 MG/ML [Gastrocrom] SBDC · 831268
  • Cromolyn Oral Solution [Gastrocrom] SBDF · 364684
  • Cromolyn sodium Oral Solution [Gastrocrom] SBDFP · 2657432
  • Gastrocrom Oral Liquid Product SBDG · 1176658
  • Gastrocrom Oral Product SBDG · 1176659
  • Gastrocrom BN · 217266

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 831261 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00037-0678-96 12 POUCH in 1 CARTON (0037-0678-96) / 8 AMPULE in 1 POUCH (... Gastrocrom Viatris Specialty LLC 2015-05-01
16571-0600-96 12 POUCH in 1 CARTON (16571-600-96) / 8 AMPULE in 1 POUCH /... CROMOLYN SODIUM Rising Pharma Holdings, Inc. 2011-12-05
42571-0132-52 96 CARTON in 1 CARTON (42571-132-52) / 1 TRAY in 1 CARTON /... CROMOLYN SODIUM Micro Labs Limited 2013-05-04
76204-0025-96 12 POUCH in 1 CARTON (76204-025-96) / 8 AMPULE in 1 POUCH (... Cromolyn Sodium Oral Solution (Concentrate) Ritedose Pharmaceuticals, LLC 2021-12-01
81665-0104-96 12 POUCH in 1 CARTON (81665-104-96) / 8 AMPULE in 1 POUCH /... CROMOLYN SODIUM Omnivium Pharmaceuticals LLC 2024-08-31
Observed labelers: Micro Labs Limited (1) · Omnivium Pharmaceuticals LLC (1) · Rising Pharma Holdings, Inc. (1) · Ritedose Pharmaceuticals, LLC (1) · Viatris Specialty LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.